Biomerica (BMRA) Operating Leases (2019 - 2025)

Biomerica has disclosed Operating Leases across 7 years of filings, most recently posting $373000.0 for Q3 2025.

• Operating Leases for Q3 2025 came in at $373000.0, down 47.24% year-over-year; the trailing twelve-month figure through Aug 2025 was $373000.0 (down 47.24% YoY), and the FY2025 annual result was $100000.0, down 78.21% from the prior year.
• Operating Leases came in at $373000.0 for Q3 2025 at Biomerica, up from $100000.0 in the prior quarter.
• In the past five years, Operating Leases ranged from a high of $1.4 million in Q1 2022 to a low of $100000.0 in Q2 2025.
• The 5-year median for Operating Leases is $901449.0 (2022), against an average of $860307.2.
• Across the five-year window, Operating Leases advanced 6.83% in 2022 and plunged 78.21% in 2025, its largest moves.
• Biomerica's Operating Leases stood at $1.2 million in 2021, then fell by 22.74% to $901449.0 in 2022, then gained by 3.94% to $937000.0 in 2023, then plunged by 33.19% to $626000.0 in 2024, then plunged by 40.42% to $373000.0 in 2025.
• The last three Operating Leases figures came in at $373000.0 (Q3 2025), $100000.0 (Q2 2025), and $193000.0 (Q1 2025), per Business Quant data.